Back to Depression And Anxiety
NCT01195740
NCT01195740
Who may be able to join
Who might be able to join this trial:
- You are currently receiving inpatient mental health treatment
- You have made a suicide attempt within the past month
- You have a main caregiver (such as a parent or guardian) who is willing to take part in follow-up care after treatment
- You are able to travel to CHOP (Children's Hospital of Philadelphia)
- You do not have a history of psychosis or significant intellectual disability
- You can speak and understand English well enough to participate
Who may not be able to join:
- You are being discharged to a residential care placement (such as a group home or residential facility) rather than returning home
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 2
Sponsor
Children's Hospital of Philadelphia
Registry
clinicaltrials_gov
Start date
1 July 2008
Est. completion
1 November 2011
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
Client Satisfaction Questionnaire (CSQ); Cornell Services Index (CSI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.